Use of Telepsychiatry in Pediatric Emergency Room to Decrease Length of Stay for Psychiatric Patients, Improve

Aaron Reliford1,2, Blessing Adebanjo1

  • 1Department of Psychiatry, Harlem Hospital, New York, New York.

Insights

Telepsychiatry significantly reduced travel time for psychiatric evaluations, saving an average of 2.22 hours per day. This innovative approach improved patient access and healthcare efficiency.

Area of Science:

  • Healthcare Management
  • Telemedicine
  • Psychiatry

Background:

  • Traditional in-person psychiatric evaluations involve significant travel time and logistical challenges.
  • The adoption of telemedicine offers a potential solution to improve access and efficiency in mental healthcare delivery.

Purpose of the Study:

  • To evaluate the impact of telepsychiatry on travel reduction and time savings for psychiatric evaluations.
  • To assess the efficiency gains associated with implementing telepsychiatry services.

Main Methods:

  • A comparative analysis of travel time and evaluation duration was conducted.
  • Data was collected on telepsychiatry usage and compared to in-person evaluation benchmarks.

Main Results:

  • Telepsychiatry reduced travel for face-to-face evaluations by 75%.
  • An average of 2.22 hours were saved per call day through telepsychiatry implementation.
  • Statistical significance was observed in time savings compared to prior periods (p=0.032, p=0.017).

Conclusions:

  • Telepsychiatry is an effective method for reducing travel burdens in psychiatric care.
  • The implementation of telepsychiatry leads to substantial time savings and improved operational efficiency.
  • Telepsychiatry enhances the accessibility and delivery of mental health services.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
325
Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
290